Furthermore, Grabosch et al. demonstrated that neoadjuvant chemotherapy with cisplatin enhanced tumor immunogenicity and upregulated PD-L1 expression in ovarian cancer mouse models. This evidence concerns the gene CD274 and ovarian cancer.